Selenium and Selenoprotein Deficiencies Induce Widespread Pyogranuloma Formation in Mice, while High Levels of Dietary Selenium Decrease Liver Tumor Size Driven by TGFα

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Moustafa, Mohamed E ^a,h   Carlson, Bradley A ^a   Anver, Miriam R ^b   Bobe, Gerd ^c   Zhong, Nianxin ^a   Ward, Jerrold M ^d   Perella, Christine M ^b   Hoffmann, Victoria J ^a   Rogers, Keith ^b,i   Combs, Gerald F ^e   Schweizer, Ulrich ^f   Merlino, Glenn ^a   Gladyshev, Vadim N ^g   Hatfield, Dolph L ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^c OREGON STATE UNIVERSITY   (United States)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e GRAND FORKS HUMAN NUTRITION RESEARCH CENTER   (United States)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

^h Alexandria University Faculty Of Science   (Egypt)

ⁱ INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

SELENIUM; SELENOPROTEIN; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INCIDENCE; CONTROLLED STUDY; DIETARY INTAKE; HETEROZYGOSITY; HOMOZYGOSITY; INFLAMMATION; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PYOGRANULOMA; SELENIUM DEFICIENCY; SELENOPROTEIN DEFICIENCY; TISSUE DISTRIBUTION; TRANSGENE; TUMOR VOLUME;

EID: 84874512506     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057389     Document Type: Article

References (39)

1. Hatfield DL, Berry MJ, Gladyshev VN (2012) Selenium: Its molecular biology and role in human health. New York, NY: Springer Science+Business Media, LLC. 598 p.
2. Rayman MP, (2005) Selenium in cancer prevention: a review of the evidence and mechanism of action. Proc Nutr Soc 64: 527-542.
3. Brigelius-Flohe R, (2008) Selenium compounds and selenoproteins in cancer. Chem Biodivers 5: 389-395.
4. Ip C, Lisk DJ, Ganther HE, (2000) Chemoprevention with triphenylselenonium chloride in selenium-deficient rats. Anticancer Res 20: 4179-4182.
5. Carlson BA, Yoo MH, Tsuji PA, Gladyshev VN, Hatfield DL, (2009) Mouse models targeting selenocysteine tRNA expression for elucidating the role of selenoproteins in health and development. Molecules 14: 3509-3527.
6. Conrad M, Schweizer U, (2010) Unveiling the molecular mechanisms behind selenium-related diseases through knockout mouse studies. Antioxid Redox Signal 12: 851-865.
7. Kasaikina MV, Hatfield DL, Gladyshev VN, (2012) Understanding selenoprotein function and regulation through the use of rodent models. Biochim Biophys Acta. 1823: 1633-1642.
8. Novoselov SV, Calvisi DF, Labunskyy VM, Factor VM, Carlson BA, et al. (2005) Selenoprotein deficiency and high levels of selenium compounds can effectively inhibit hepatocarcinogenesis in transgenic mice. Oncogene 24: 8003-8011.
9. Felix K, Gerstmeier S, Kyriakopoulos A, Howard OM, Dong HF, et al. (2004) Selenium deficiency abrogates inflammation-dependent plasma cell tumors in mice. Cancer Res 64: 2910-2917.
10. Irons R, Carlson BA, Hatfield DL, Davis CD, (2006) Both selenoproteins and low molecular weight selenocompounds reduce colon cancer risk in mice with genetically impaired selenoprotein expression. J Nutr 136: 1311-1317.
11. Diwadkar-Navsariwala V, Prins GS, Swanson SM, Birch LA, Ray VH, et al. (2006) Selenoprotein deficiency accelerates prostate carcinogenesis in a transgenic model. Proc Natl Acad Sci U S A 103: 8179-8184.
12. Hudson TS, Carlson BA, Hoeneroff MJ, Young HA, Sordillo L, et al. (2012) Selenoproteins reduce susceptibility to DMBA-induced mammary carcinogenesis. Carcinogenesis 33: 1-6.
13. Moustafa ME, Carlson BA, El-Saadani MA, Kryukov GV, Sun QA, et al. (2001) Selective inhibition of selenocysteine tRNA maturation and selenoprotein synthesis in transgenic mice expressing isopentenyladenosine-deficient selenocysteine tRNA. Mol Cell Biol 21: 3840-3852.
14. Carlson BA, Xu XM, Gladyshev VN, Hatfield DL, (2005) Selective rescue of selenoprotein expression in mice lacking a highly specialized methyl group in selenocysteine tRNA. J Biol Chem 280: 5542-5548.
15. Carlson BA, Moustafa ME, Sengupta A, Schweizer U, Shrimali R, et al. (2007) Selective restoration of the selenoprotein population in a mouse hepatocyte selenoproteinless background with different mutant selenocysteine tRNAs lacking Um34. J Biol Chem 282: 32591-32602.
16. Jhappan C, Stahle C, Harkins RN, Fausto N, Smith GH, et al. (1990) TGF alpha overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell 61: 1137-1146.
17. Schomburg L, Schweizer U, Holtmann B, Flohe L, Sendtner M, et al. (2003) Gene disruption discloses role of selenoprotein P in selenium delivery to target tissues. Biochem J 370: 397-402.
18. Schweizer U, Michaelis M, Kohrle J, Schomburg L, (2004) Efficient selenium transfer from mother to offspring in selenoprotein-P-deficient mice enables dose-dependent rescue of phenotypes associated with selenium deficiency. Biochem J 378: 21-26.
19. Hill KE, Zhou J, McMahan WJ, Motley AK, Burk RF, (2004) Neurological dysfunction occurs in mice with targeted deletion of the selenoprotein P gene. J Nutr 134: 157-161.
20. Valentine WM, Hill KE, Austin LM, Valentine HL, Goldowitz D, et al. (2005) Brainstem axonal degeneration in mice with deletion of selenoprotein p. Toxicol Pathol 33: 570-576.
21. Wirth EK, Conrad M, Winterer J, Wozny C, Carlson BA, et al. (2010) Neuronal selenoprotein expression is required for interneuron development and prevents seizures and neurodegeneration. FASEB J 24: 844-852.
22. Davis CD, Uthus EO, (2002) Dietary selenite and azadeoxycytidine treatments affect dimethylhydrazine-induced aberrant crypt formation in rat colon and DNA methylation in HT-29 cells. J Nutr 132: 292-297.
23. Hatfield D, Matthews CR, Rice M, (1979) Aminoacyl-transfer RNA populations in mammalian cells chromatographic profiles and patterns of codon recognition. Biochim Biophys Acta 564: 414-423.
24. Kelmers AD, Heatherly DE, (1971) Columns for rapid chromatographic separation of small amounts of tracer-labeled transfer ribonucleic acids. Anal Biochem 44: 486-495.
25. McShane LM, Clark LC, Combs GF Jr, Turnbull BW, (1991) Reporting the accuracy of biochemical measurements for epidemiologic and nutrition studies. Am J Clin Nutr 53: 1354-1360.
26. Song E, Jaishankar GB, Saleh H, Jithpratuck W, Sahni R, et al. (2011) Chronic granulomatous disease: a review of the infectious and inflammatory complications. Clin Mol Allergy 9: 10.
27. Coash M, Forouhar F, Wu CH, Wu GY, (2012) Granulomatous liver diseases: a review. J Formos Med Assoc 111: 3-13.
28. Santoro D, Prisco M, Ciaramella P, (2008) Cutaneous sterile granulomas/pyogranulomas, leishmaniasis and mycobacterial infections. J Small Anim Pract 49: 552-561.
29. Williams GT, Williams WJ, (1983) Granulomatous inflammation-a review. J Clin Pathol 36: 723-733.
30. Sunde RA, Raines AM, Barnes KM, Evenson JK, (2009) Selenium status highly regulates selenoprotein mRNA levels for only a subset of the selenoproteins in the selenoproteome. Biosci Rep 29: 329-338.
31. Hatfield D, Lee BJ, Hampton L, Diamond AM, (1991) Selenium induces changes in the selenocysteine tRNA[Ser]Sec population in mammalian cells. Nucleic Acids Res 19: 939-943.
32. Murakami H, Sanderson ND, Nagy P, Marino PA, Merlino G, et al. (1993) Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis. Cancer Res 53: 1719-1723.
33. Carlson BA, Yoo MH, Tobe R, Mueller C, Naranjo-Suarez S, et al. (2012) Thioredoxin reductase 1 protects against chemically induced hepatocarcinogenesis via control of cellular redox homeostasis. Carcinogenesis 33: 1806-1813.
34. Tsuji PA, Carlson BA, Naranjo-Suarez S, Yoo MH, Xu XM,et al. (2012) Knockout of the 15 kDa selenoprotein protects against chemically-induced aberrant crypt formation in mice. PLoS One. In Press.
35. Hatfield DL, Yoo MH, Carlson BA, Gladyshev VN, (2009) Selenoproteins that function in cancer prevention and promotion. Biochim Biophys Acta 1790: 1541-1545.
36. Vunta H, Davis F, Palempalli UD, Bhat D, Arner RJ, et al. (2007) The anti-inflammatory effects of selenium are mediated through 15-deoxy-Delta12,14-prostaglandin J2 in macrophages. J Biol Chem 282: 17964-17973.
37. Carlson BA, Yoo MH, Shrimali RK, Irons R, Gladyshev VN, et al. (2010) Role of selenium-containing proteins in T-cell and macrophage function. Proc Nutr Soc 69: 300-310.
38. Hatfield DL, Carlson BA, Xu XM, Mix H, Gladyshev VN, (2006) Selenocysteine incorporation machinery and the role of selenoproteins in development and health. Prog Nucleic Acid Res Mol Biol 81: 97-142.
39. Brigelius-Flohe R, Kipp A, (2009) Glutathione peroxidases in different stages of carcinogenesis. Biochim Biophys Acta 1790: 1555-1568.